Accessibility Menu
Otsuka logo

Otsuka(OTC) OTSKF

Market Cap$39.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+199%
5 Year+102%
1 Year+74%
1 Month+14%
$76.10
-1.69%
-1.31Today
Otsuka last closing stock price
MetricPriceDate
Last closeUSD 76.102026-09-02
Otsuka stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.69%USD 77.412026-08-26
1 month+14.44%USD 66.502026-08-03
3 month+18.38%USD 64.292026-06-04
Year to date+41.57%USD 53.752025-12-31
1 year+74.34%USD 43.652025-08-25
3 year+111.38%USD 36.002023-09-01
5 year+101.68%USD 37.732021-08-17
Since inception+198.7%USD 25.482011-06-06

Otsuka Financials at a Glance

Market Cap

$39.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥2.63T

Net Income (TTM)

¥406.84B

EPS (TTM)

$4.98

P/E Ratio

15.27

Dividend

$1.06

Beta (Volatility)

0.08 (Low)

Price

$76.10

Volume

1,165

Open

$76.10

Previous Close

$76.10

Daily Range

$76.10 - $76.10

52-Week Range

$44.40 - $79.00

Estimated Earnings Date

Nov 4, 2026

OTSKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Otsuka

Otsuka Holdings Co., Ltd. is a diversified healthcare company based in Tokyo, Japan, focusing on pharmaceuticals, nutraceuticals, and consumer products. The company operates through various segments, including therapeutic drugs, nutritional products, and functional chemicals, aiming to improve health and well-being globally.

Products and Services
  • Pharmaceuticals: Therapeutic drugs for central nervous system, oncology, and infectious diseases
  • Nutraceuticals: Nutrition products, health drinks, and dietary supplements
  • Consumer Products: Mineral water, food, and beverages
Growth Outlook
  • Revenue increased to JPY 696.97 billion in Q2 2026, up from JPY 634.31 billion in Q1 2026
  • Net income rose to JPY 116.41 billion in Q2 2026, reflecting strong operational performance
  • Operating income margin improved to 20.76% in Q2 2026, indicating efficient cost management
Financial Highlights
  • Trailing twelve-month revenue of JPY 2.63 trillion, showcasing consistent growth
  • Net profit margin of 15.46% for the trailing twelve months, indicating strong profitability
  • Dividend yield of 1.39%, providing a return to shareholders
Otsuka Holdings Co., Ltd. has established a strong presence in the healthcare sector, with a focus on innovation and quality. The company's diverse product offerings cater to various health needs, positioning it well for future growth. Recent financial performance highlights a robust revenue trajectory and effective cost management, contributing to improved profitability. The company's commitment to research and development further enhances its potential for long-term success. With a solid dividend yield, Otsuka Holdings presents an attractive opportunity for investors seeking exposure to the healthcare industry.
AI Generated • Aug 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

37,758

CEO

Makoto Inoue

Website

www.otsuka.com

Headquarters

Tokyo, TY 101-0048, JP

OTSKF Financials

Key Financial Metrics (TTM)

Gross Margin

71.78%

Operating Margin

17.26%

Net Income Margin

15.46%

Return on Equity

13.24%

Return on Capital

12.65%

Return on Assets

9.22%

Earnings Yield

6.55%

Dividend Yield

1.39%

Payout Ratio

18.84%

Stock Overview

Market Cap

$39.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

525.08M

Volume

1.17K

Avg. Volume

276.359

Financials (TTM)

Gross Profit

¥1.89T

Operating Income

¥453.75B

EBITDA

¥617.71B

Operating Cash Flow

¥409.45B

Capital Expenditure

-¥87.41B

Free Cash Flow

¥322.04B

Cash & ST Invst.

¥466.15B

Total Debt

¥192.80B

Otsuka Performance Analysis

Otsuka annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 13,213,935,879-3.1%
20232023-12-31JPY 14,355,494,6778.6%
20242024-12-31JPY 15,379,137,8237.1%
20252025-12-31JPY 16,503,342,2187.3%
Otsuka sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.2%
Q42025-12-310.6%
Q12026-03-31-2.5%
Q22026-06-309.9%
Otsuka annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 1.88-10.8%
20232023-12-31JPY 1.59-15.1%
20242024-12-31JPY 4.18162.5%
20252025-12-31JPY 4.589.5%
Otsuka sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3042.6%
Q42025-12-31-48.2%
Q12026-03-3150.9%
Q22026-06-3018.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

¥696.97B

+16.6%

Gross Profit

¥506.54B

+18.0%

Gross Margin

72.68%

N/A

Market Cap

$39.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.06M

N/A

Employees

37,758

N/A

Net Income

¥116.41B

+31.5%

EBITDA

¥175.54B

+31.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

¥466.15B

+13.4%

Total Debt

¥192.80B

-8.8%

Accounts Receivable

¥591.08B

+18.2%

Inventory

¥410.92B

+17.2%

Long Term Debt

¥163.47B

+6.3%

Short Term Debt

¥29.33B

-49.2%

Return on Assets

9.22%

N/A

Return on Invested Capital

12.37%

N/A

Free Cash Flow

¥87.80B

+7.4%

Operating Cash Flow

¥107.44B

+0.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TEVJFTeva Pharmaceutical Industries Limited
$37.00+0.00%
ALPMYAstellas Pharma Inc.
$15.47+2.31%
ORINYOrion Oyj
$47.13+2.98%
ALPMFAstellas Pharma Inc.
$14.81+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About OTSKF

What is the current price of Otsuka?

Otsuka is trading at $76.10 per share.

What is the 52-week range for Otsuka?

Over the past 52 weeks, Otsuka has traded between $44.40 and $79.00.

How much debt does Otsuka have?

As of the most recent reporting period, Otsuka reported total debt of ¥1.19B.

How much cash does Otsuka have on hand?

Otsuka reported ¥2.89B in cash and cash equivalents in its most recent financial results.

What is Otsuka’s dividend yield?

Otsuka currently has a dividend yield of 1.39%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services